Poland - Antineoplastic agents - Supply of parenteral nutrition drugs, special medical purpose products with pump leases, pharmaceutical raw materials and compounding utensils

different companies won its awards

270

of the awards went to the three most frequent winners

5%

of its calls state an estimated value

0%

Based on 287 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.

Competition

tenders per lot on average (open and restricted procedures)

1.7

of those lots received a single tender

62%

of the awards went to companies based in another country

1%

As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.

Poland · Medical equipment & pharmaceuticals

different companies won awards here

13,522

of the awards went to the three most frequent winners

4%

buyers awarded contracts here

1,465

Based on 23,161 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.

Competition

tenders per lot on average (open and restricted procedures)

1.8

of those lots received a single tender

63%

of the awards went to companies based in another country

2%

of the tenders came from another country

2%

As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.